CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 193 enrolled
Drug / intervention
Chest tube placementdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03167723
NCT03167723N/ACompleted

Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions

Wake Forest University Health Sciences·interventional·Posted May 30, 2017·Updated Mar 29, 2023

In Brief

A clinical study evaluating Chest tube placement for Hemothorax and 3 related conditions. Completed, enrolled 193 participants across 1 site.

Detailed Summary

Traumatic hemothorax and hemopneumothorax are common diagnoses which are typically treated by placement of a chest tube. 28-32 Fr chest tubes have previously been shown equivalent to 36-40 Fr chest tubes for the non-emergent drainage of hemothorax. A smaller study has found 14 Fr pigtails had less pain than larger tubes but was not powered to compare outcomes. We seek to perform a prospective randomized trial that is adequately powered comparing efficacy of 14 Fr thal tubes to 28 Fr chest tubes for non-emergent drainage of hemothorax and hemopneumothorax. Additionally, we will employ maximal barrier precautions for all chest tube insertions and compare empyema rates to our historical controls.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 30, 2017
Enrollment StartMay 8, 2017
Primary CompletionDec 20, 2021
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 9.1 years ago

Interventions

Chest tube placementdevice

Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.